We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AiCuris Gained Bio.NRW Research Promotion
News

AiCuris Gained Bio.NRW Research Promotion

AiCuris Gained Bio.NRW Research Promotion
News

AiCuris Gained Bio.NRW Research Promotion

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AiCuris Gained Bio.NRW Research Promotion"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AiCuris GmbH & Co. KG has been awarded a three-year research grant together with the Universities of Bochum, Duesseldorf and Bonn as well as the company Squarix (Marl). This grant is a part of the research promotion program “Bio.NRW” by the Ministry of Innovation, Science and Research of North Rhine-Westphalia. AiCuris will obtain 833,582 Euro.

The project “Innovative Antibiotics made in NRW” is aimed to enable research and development of new antibiotics effective against life threatening multi-resistant bacteria e.g. the hospital agent MRSA (Methicillin-resistant Staphylococcus aureus).

The grant is composed from funds of the “Ziel 2 – Programm NRW 2007-20013” (European fund for regional development) and from the Ministry of Innovation, Science and Research of North Rhine-Westphalia.

In its project AiCuris will evaluate the optimization potential of underexplored natural products together with other members of the consortium. The aim is to identify a development candidate with resistance breaking properties as a new weapon to combat resistant bacteria.
Advertisement